Universal Biosensors, Inc. Board of Directors

Mr Andrew Denver BSc (Hons), MBA, FAICD
Chairman



Between 2002 and 2005, Andrew was President of Pall Asia, a subsidiary of Pall Corporation, with responsibility for all Pall Corporation activities in the Asia Pacific region.

Andrew joined Pall in 2002 with the acquisition by Pall Corporation of US Filter’s Filtration and Separations business, where he was President. Andrew was appointed President and Chief Operating Officer of the US Filter Filtration and Separations Group in February 1998 after US Filter acquired Memtec Limited. Prior to his position at US Filter, Andrew was President and Chief Operating Officer of Memtec Limited from 1987 to 1997, and prior to that, at Baxter Healthcare Corporation where he was employed for 12 years in a number of positions. Andrew’s last assignment at Baxter Healthcare Corporation was as President of the corporation’s US based Medical Devices Division.

Andrew is a foundation member of The Principals Funds Management Pty Ltd, which helps Australian technology businesses commercialise their technologies. Andrew was a founding member and director of the Australian Environment Management Export Corporation and was the inaugural chairman for the first two years. Andrew was also a founding member and director of the Environment Management Industry Association of Australia. Andrew is a non-executive director of SpeeDx Pty Ltd and Cochlear Ltd, and until September 2010 and October 2008, was also a non-executive director of CathRx Ltd and Anzon Australia Ltd, respectively.

Andrew graduated from the University of Manchester with a Bachelor of Science Degree (Honours) in Chemistry and achieved a distinction in his MBA at the Harvard Business School and is a Fellow of the Australian Institute of Company Directors. Andrew was appointed as a Director of Universal Biosensors on 31 December 2002 and as interim Chief Executive Officer on 9th September 2010.

Mr Paul Wright M.A., F.A.I.C.D.
Chief Executive Officer



Mr. Wright was appointed as Chief Executive Officer and a director of the Company on February 24, 2011with an effective date of March 1, 2011. Mr. Wright has experience as Chief Executive Officer with two global technology companies and extensive experience in international management consulting and commercial development with a focus on manufacturing industries. Between 2008 and 2011, Paul Wright has acted as a company director for two Australian private companies (Metallic Waste Solutions Pty Ltd and Comcater Pty Ltd). During 2006 and 2007, Mr. Wright was Chief Executive Officer of Vision BioSystems, a major subsidiary of Vision Systems Limited, which develops, manufactures and markets diagnostic instruments and consumables worldwide. Following the acquisition of Vision Systems Limited by Danaher Corporation in 2006, Mr. Wright worked for Danaher Corporation to assist with the integration of Vision Systems into the new parent until 2007. From 1999 to 2006, Mr. Wright was Chief Executive Officer of Invetech, a leading international product development consultancy. Prior to this, Mr. Wright gained extensive experience in international strategy consulting and commercial development, with a focus on manufacturing industries including roles at TNT Logistics and Bain & Company. Mr. Wright holds a Masters degree in Aeronautical Engineering from the University of Cambridge, a Diploma in Production Methods & Management from the University of Cambridge and has studied Corporate Finance at the London Business School. Mr. Wright is a Fellow of the Australian Institute of Company Directors.

Dr Colin Adam BE (Met), PhD
Non-Executive Director



During 2000, Colin was the Acting Chief Executive of the Commonwealth Scientific and Industrial Research Organisation ('CSIRO'). The CSIRO is the peak Australian Government body with a mission for technological development and industrial research and development. Prior to that, Colin was Deputy Chief Executive directly responsible for all the CSIRO's commercial activity.

Colin's career has included technology management positions within the US aerospace industry as Program Manager in advanced alloy development for Pratt & Whitney Aircraft in Florida and as Manager of the Materials Laboratory for Allied Corporation in New Jersey.

Colin subs equently became director of the Metals and Ceramics Laboratory, Corporate Technology for Allied. Colin has served as a member of the Commonwealth Government's Industry Research and Development Board, the Australian Prime Minister's Science Engineering and Innovation Council and the Victorian Premier's Science, Engineering and Technology Taskforce. Colin serves on the board of PFM Cornerstone Ltd, The Principals Funds Management Pty Ltd and CathRx Ltd. Colin was previously a director of Ausmelt Ltd, Ceramic Fuel Cells Ltd, Memtec Limited, Melbourne IT Limited, and was Chairman of Tele IP Ltd and The Preston Group, an aviation software company sold to Boeing in 1999.

Colin has a Bachelor of Metallurgical Engineering Degree and a PhD in Metallurgy from the University of Queensland. Colin has been a director of Universal Biosensors Australia since 10 July 2002.

Mr Denis Hanley AM, MBA, FCPA, FAICD
Non-Executive Director



Denis Hanley is a qualified accountant and company director with more than 35 years experience in the management of technology-based growth businesses.

Denis spent 14 years with Baxter International Inc., a global medical products and services company. His career at Baxter included a number of international assignments including its Chicago headquarters, and his last position was Managing Director of Baxter's Australian operations. In 1983, Denis was founding Chief Executive Officer and, in 1986, Executive Chairman of the Australian-based separations technology company, Memtec Limited. Under his leadership, Memtec grew into a global operating filtration and separations business with 1,700 employees, listed on the New York Stock Exchange. Since the sale of Memtec to US Filter in 1997, Denis has been a successful angel investor, assisting the commercialisation of several Australian technologies. Denis is non-Executive Chairman of Pharmaxis Ltd and CathRx Ltd.

Denis holds an MBA with High Distinction from Harvard Graduate School of Business, where he was named a Baker Scholar. Denis was appointed as a Director on 21 September 2001.

Mr Andrew Jane BSc (Hons), MSc
Non-Executive Director



Andrew joined CM Capital Investments Pty Ltd in 2003 as an Investment Manager and was promoted to Partner in 2006. Andrew began his career in academic research and the CSIRO and prior to becoming a venture capitalist, had a successful 10 year career in small entrepreneurial technology companies working in Australia, Japan and the US. Andrew is currently a director of Advent Pharmaceuticals Pty Limited, Piedmont Phamaceuticals Inc., Piedmont Pharmaceuticals Pty Ltd, Altitis Therapeutics, Inc., SpeeDx Pty Ltd and is an observer to the Board of Metastatix, Inc. and Osprey Medical, Inc.

In 1994 Andrew was recruited to lead AGEN Biomedical Limited's biosensor and instrumentation program which played a key role in the rapid expansion of AGEN's export sales into the US. Andrew's other major contribution at AGEN was to be the original internal start-up entrepreneur for the in vivo diagnostic imaging program for detecting blood clots, known as Thromboview, now in global Phase II trials.

In 1999 Andrew left AGEN and joined Lake Technology prior to its successful ASX listing later that year. As director of business development and licensing, Andrew worked closely with Lake Technology's strategic partner, Dolby Laboratories in San Francisco, and was responsible for a significant number of global licensing deals during his four years there. The rapid growth of the company was recognised by Dolby, which acquired Lake Technology in 2004.

Andrew received his MSc in Instrumentation from the University of Manchester Institute of Science and Technology and holds a BSc (Honours) in Physics from St Andrews University in Scotland. Andrew was appointed as a Director on 15 August 2006.

Mr. Marshall Heinberg B.S (Hons), J.D.
Non-Executive Director

Mr. Heinberg has extensive experience and insight into the global capital markets and has worked with several life science and technology companies. Mr. Heinberg was appointed a non-executive director of the Company in January 2010.

Mr. Heinberg is head of Oppenheimer's Investment Banking Department and a Senior Managing Director of the firm. Mr. Heinberg began his investment banking career in 1987 as an Associate in the Corporate Finance Division of Oppenheimer & Company, which was acquired by the Canadian Imperial Bank of Commerce (CIBC) in 1997.

Over the course of his career, Mr. Heinberg has held responsibility for various industry sectors including environmental, industrial growth, technology and telecommunications. His transaction experience includes public and private financings, exclusive sale and strategic advisory assignments. Mr. Heinberg was named Head of CIBC's U.S. Investment Banking Department in 2001. Upon the acquisition of CIBC's U.S. wholesale business in 2008, Mr. Heinberg was named head of Oppenheimer's Investment Banking Department. Marshall is a director of Image Entertainment, Inc.

Mr. Heinberg has extensive experience working with both leading growth companies as well as financial sponsors. Prior to joining Oppenheimer, Mr. Heinberg practiced corporate law for approximately four years. Mr. Heinberg graduated from the University of Pennsylvania, the Wharton School with honors, with a degree in economics. He received his law degree from Fordham Law School.


Dr Elizabeth (Jane) Wilson MBBS, MBA, FAICD
Non-Executive Director



Jane is a professional company director with a background in medicine and finance. Jane has an MBA from the Harvard Business School where she studied agribusiness and the health sector. Jane is the current Chairman of IMBcom Limited (the commercialisation company of the Institute for Molecular Bioscience) and is Past President of the Australian Institute of Company Directors – Queensland Division, as well as a director of Sonic Healthcare Ltd and CathRx Ltd.

Jane is Finance Director of the Winston Churchill Memorial Trust and was the inaugural Chair of Horticulture Australia Ltd from 2000 to 2004. Jane is involved in a number of charitable and cultural organisations and has also served on the Queensland Government Biotechnology Taskforce, and the boards of Energex Ltd, WorkCover Queensland, AGEN Biomedical Limited and Protagonist Ltd. Jane was an inaugural member of the Queensland Premier's Smart State Council and is a member of the University of Queensland Senate.